Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Authors :
Alvarez-Perez B; Laboratory of Neuropharmacology, Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona, Spain.; Poras H
Subjects: Neprilysin* ; Opioid-Related Disorders*; Humans
-
Source:
British journal of pharmacology [Br J Pharmacol] 2023 Apr; Vol. 180 (7), pp. 879-893. Date of Electronic Publication: 2021 Dec 06.Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Richards AM; Christchurch Heart Institute, University of Otago, Christchurch, New Zealand.; Cardiovascular Research Institute, National University of Singapore, Singapore.
Subjects: Heart Failure* ; Neprilysin*; Aminobutyrates
-
Source:
European journal of heart failure [Eur J Heart Fail] 2019 May; Vol. 21 (5), pp. 606-608. Date of Electronic Publication: 2019 Mar 18.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:
Record details
-
Authors :
Ambrosy AP; Division of Cardiology, Duke University Medical Center, Durham, NC, USA.; Duke Clinical Research Institute, Durham, NC, USA.
Subjects: Health Knowledge, Attitudes, Practice* ; Practice Guidelines as Topic*; Angiotensin Receptor Antagonists/Angiotensin Receptor Antagonists/Angiotensin Receptor Antagonists/*therapeutic use
-
Source:
European journal of heart failure [Eur J Heart Fail] 2018 Jun; Vol. 20 (6), pp. 963-972. Date of Electronic Publication: 2018 Feb 21.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium:
Record details